4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-064812
Options or other derivatives
- Director acquired 47,165 shares (grant or award)
From the SEC's structured data for this filing
Denali Therapeutics Inc. Filed Acc 0001209191-17-064812
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…